Reproducibility of Anaerobic and Pain Thresholds in Male Patients With Intermittent Claudication

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
COSTA, Luiz Augusto Riani
LEICHT, Anthony Scott
RITTI-DIAS, Raphael Mendes
FORJAZ, Claudia Lucia de Moraes
Citação
JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, v.36, n.5, p.358-367, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
PURPOSE: Maximal and submaximal parameters assessed during treadmill tests are used to prescribe exercise training and assess exercise-induced adaptations in patients with intermittent claudication (IC). Although reproducibility of maximal parameters is well documented, the reproducibility of submaximal is not clear. The aim of this study was to identify the reproducibility (reliability and agreement) of heart rate (HR) and oxygen uptake (o(2)) measured at the anaerobic (AT) and the pain (PT) thresholds assessed during a maximal test in patients with IC. METHODS: Twenty male patients with IC underwent 2 cardiopulmonary treadmill tests to maximal pain. The HR ando(2) at the AT and PT were identified, and differences between repeat tests were compared. Reliability was determined by intraclass coefficient correlation (ICC). Agreement was assessed by coefficient of variation (CV), standard error of measurement (SEM), smallest detectable difference (SDD), and limits of agreement (LOA). RESULTS: The o(2) at AT and PT exhibited moderate reliability and moderate/good agreement (ICC = 0.73 and 0.70; CV = 9.6% and 11.1%, respectively). The HR at the AT and PT exhibited high reliability and good agreement (ICC = 0.87 and 0.92; SEM = 3.9 and 3.2 bpm; SDD = 10.8 and 8.8 bpm, respectively). The LOA for o(2) at AT and PT were 20% and for HR 11 bpm. CONCLUSIONS: The o(2) and HR measured at the AT and PT were moderately to highly reproducible in male patients with IC. The HR and o(2) at AT and PT may be used to establish training intensity and evaluate training effectiveness for these patients in clinical practice and research.
Palavras-chave
agreement, cardiopulmonary exercise test, exercise prescription, peripheral artery disease, reliability
Referências
  1. Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69
  2. Bauer TA, 1999, J APPL PHYSIOL, V87, P809
  3. Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4
  4. BLAND JM, 1986, LANCET, V1, P307
  5. Blankevoort CG, 2013, PHYS THER, V93, P69, DOI 10.2522/ptj.20110164
  6. Bronas UG, 2011, J VASC SURG, V53, P1557, DOI 10.1016/j.jvs.2011.01.077
  7. Bruton A., 2000, PHYSIOTHERAPY, V86, P94, DOI 10.1016/S0031-9406(05)61211-4
  8. Cucato GG, 2013, CLINICS, V68, P974, DOI 10.6061/clinics/2013(07)14
  9. de Groot JF, 2011, PHYS THER, V91, P267, DOI 10.2522/ptj.20100069
  10. de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015
  11. Degischer S, 2002, J VASC SURG, V36, P83, DOI 10.1067/mva.2002.123092
  12. Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P322, DOI 10.1053/apmr.2002.29622
  13. Gardner AW, 2007, J VASC SURG, V46, P1208, DOI 10.1016/j.jvs.2007.07.038
  14. GARDNER AW, 1991, MED SCI SPORT EXER, V23, P402
  15. Garg PK, 2006, CIRCULATION, V114, P242, DOI 10.1161/CIRCUALTIONAHA.105.605246
  16. HENRITZE J, 1985, EUR J APPL PHYSIOL O, V54, P84, DOI 10.1007/BF00426304
  17. Hiatt WR, 2008, CIRCULATION, V118, P2826, DOI 10.1161/CIRCULATIONAHA.108.191171
  18. Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526
  19. Jacobson TA, 2014, J CLIN LIPIDOL, V8, P473, DOI 10.1016/j.jacl.2014.07.007
  20. Kroger K, 2006, EUR J EPIDEMIOL, V21, P279, DOI 10.1007/s10654-006-0015-9
  21. Makdisse M, 2008, ARQ BRAS CARDIOL, V91, P370
  22. Martinez DG, 2011, HYPERTENSION, V58, P1049, DOI 10.1161/HYPERTENSIONAHA.111.176644
  23. Marzolini S, 2012, STROKE, V43, P1075, DOI 10.1161/STROKEAHA.111.635128
  24. Mezzani A, 2013, EUR J PREV CARDIOL, V20, P442, DOI 10.1177/2047487312460484
  25. Myers J, 2009, CIRCULATION, V119, P3144, DOI 10.1161/CIRCULATIONAHA.109.192520
  26. Myers J, 2008, HEART FAIL REV, V13, P61, DOI 10.1007/s10741-007-9051-0
  27. Nevill AM, 1997, BRIT J SPORT MED, V31, P314
  28. Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024
  29. Ritti-Dias RM, 2009, J CARDIOPULM REHABIL, V29, P396, DOI 10.1097/HCR.0b013e3181b4ca38
  30. Ritti-Dias RM, 2010, VASC MED, V15, P275, DOI 10.1177/1358863X10371415
  31. Ritti-Dias RM, 2010, J VASC SURG, V51, P89, DOI 10.1016/j.jvs.2009.07.118
  32. Robbins JL, 2011, J APPL PHYSIOL, V111, P81, DOI 10.1152/japplphysiol.00141.2011
  33. Roveda F, 2003, J AM COLL CARDIOL, V42, P854, DOI 10.1016/S0735-1097(03)00831-3
  34. SKINNER JS, 1980, RES Q EXERCISE SPORT, V51, P234
  35. Szklo R, 2000, EPIDEMIOLOGY BASIS, P343
  36. Tuner SL, 2008, J VASC SURG, V47, P123, DOI 10.1016/j.jvs.2007.09.001
  37. Wasserman K, 1994, PRINCIPLES EXERCISE, P479